AstraZeneca was among the first multinational pharmaceutical firms to invest deeply in China's healthcare sector. Through ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that purpose ...

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...

Live Updates Live Coverage Updates appear automatically as they are published. Get The Best Tempus AI Live Earnings Coverage ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...

Following a lengthy R&D process, two new molecules from Biogen could add much-needed treatments for a disease that’s been difficult to pin down.

Novo Nordisk asserts its acquisition of Metsera won't pose antitrust problems as it competes with Pfizer for dominance in the ...

AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving ...

AstraZeneca is moving ahead with a major build-out of its American footprint, tying a new facility to a broader $3.5 billion ...

If it wasn’t already clear, Virginia is doubling down on life sciences. State officials have teamed up with a trio of top ...

(Reuters) -AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on ...

The blue-chip FTSE 100 inched 0.1% to 9730.1 points by 1241 GMT, building on its near 4% jump in October, while the FTSE 250 midcap index dipped 0.1% in the session. It is shaping up to be a busy ...